Impact of HPV vaccine on male disease

Clicks: 29
ID: 318332
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #142 of 252 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 252 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Human papillomavirus infection represents a public health burden in males, contributing substantially to anogenital, head and neck cancers, and benign conditions such as anogenital warts. This article reviews the epidemiology of HPV-related disease in men, the evidence supporting HPV vaccination across age groups and risk populations, and highlights the rationale for gender-neutral vaccination programs.
Reference Key
openalex_W7165645029 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag264
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.